“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List – Biogen

1. “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List  Biogen
2. Eli Lilly’s Mounjaro added to China’s state insurance list for diabetes treatment  Reuters
3. Eli…

Continue Reading